Immunoglobulin class and immunoglobulin G subclass analysis of human anti-mouse antibody response during monoclonal antibody treatment of cancer patients
- PMID: 2297720
Immunoglobulin class and immunoglobulin G subclass analysis of human anti-mouse antibody response during monoclonal antibody treatment of cancer patients
Abstract
The immune response against murine IgG2a immunoglobulin was studied in 42 gastrointestinal cancer patients treated with mouse monoclonal antibodies. IgM, IgA, and all 4 IgG subclasses directed against mouse immunoglobulin were studied. Thirty of 42 patients developed an anti-mouse response of IgG isotype, often associated with IgM and IgA specific for mouse monoclonal antibodies circulating in serum. Patients first developed an IgM response, followed by IgA and IgG. IgG1 was found to be the most frequently expressed isotype, followed by IgG2 and IgG3. IgG4 was detected in only 6 patients.
Similar articles
-
Human anti-murine immunoglobulin responses and immune functions in cancer patients receiving murine monoclonal antibody therapy.Hum Antibodies Hybridomas. 1991 Jan;2(1):16-25. Hum Antibodies Hybridomas. 1991. PMID: 1908336
-
Development of primary and secondary immune responses to mouse monoclonal antibodies used in the diagnosis and therapy of malignant neoplasms.Cancer Res. 1986 Dec;46(12 Pt 1):6489-93. Cancer Res. 1986. PMID: 2430699
-
The human antimouse immunoglobulin response and the anti-idiotypic network have no influence on clinical outcome in patients with minimal residual colorectal cancer treated with monoclonal antibody CO17-1A.Cancer Res. 2000 Apr 1;60(7):1921-6. Cancer Res. 2000. PMID: 10766181 Clinical Trial.
-
[Production of human antimurine antibody after in vivo use of radioisotope labelled murine antibodies].Ugeskr Laeger. 1991 Sep 30;153(40):2813-5. Ugeskr Laeger. 1991. PMID: 1926613 Review. Danish.
-
Molecular properties of human IgG subclasses and their implications for designing therapeutic monoclonal antibodies against infectious diseases.Mol Immunol. 2015 Oct;67(2 Pt A):171-82. doi: 10.1016/j.molimm.2015.03.255. Epub 2015 Apr 18. Mol Immunol. 2015. PMID: 25900877 Review.
Cited by
-
Human immune response to monoclonal antibody-enzyme conjugates in ADEPT pilot clinical trial.Cell Biophys. 1992 Aug-Dec;21(1-3):109-20. doi: 10.1007/BF02789482. Cell Biophys. 1992. PMID: 1285323 Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Miscellaneous